Prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Libert? paclitaxel-eluting coronary stent placement. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

Prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Libert? paclitaxel-eluting coronary stent placement.

Garratt KN, Weaver WD, Jenkins RG, Pow TK, Mauri L, Kereiakes DJ, Winters KJ, Christen T, Allocco DJ, Lee DP. Prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Libert? paclitaxel-eluting coronary stent placement. Circulation. 2015 Jan 06; 131(1):62-73.

View in: PubMed

authors with profiles

David P. Lee

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support